23ª CONVOCATORIA INICIATIVA DE MEDICAMENTOS INNOVADORES, IMI2

La Iniciativa de Medicamentos Innovadores, IMI2, ha lanzado su 23ª convocatoria de propuestas financiándose los siguientes topics:

• Topic 1: Returning clinical trial data to study participants within a GDPR compliant and approved ethical framework     

• Topic 2: Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance

• Topic 3: A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases

• Topic 4: Optimal treatment for patients with solid tumours in Europe through artificial intelligence

• Topic 5: Shortening the path to rare disease diagnosis by using new born genetic screening and digital technologies 

• Topic 6: Behavioural model of factors affecting patient adherence

La fecha límite para presentar propuestas en la primera fase es el 29 de septiembre de 2020. 

Más información.